• Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Consensus Rating of "Moderate Buy" by Analysts

    Источник: Buzz FX / 16 ноя 2024 03:01:19   America/Chicago


    Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 16, 2024 Share Link copied to clipboard. Shares of Adverum Biotechnologies, Inc.
    Read more...
Опубликовать